Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Analytica is a global strategic advisory firm that provides geopolitical and macroeconomic analysis to help organizations navigate complex global environments. Founded in 1975 and headquartered in Oxford, UK, the company leverages a worldwide network of over 1,400 academics and specialists to deliver trusted insights and seasoned judgments. While not a biotechnology company itself, it provides critical analysis and risk assessment services to the healthcare, pharmaceutical, and life sciences sectors, helping them understand policy shifts and market volatility. The firm is well-known for its "Oxford Analytica Daily Brief," which offers daily analysis of world events for a global clientele of governments and corporations. Recently acquired by Dow Jones, it continues to operate as a key provider of geopolitical risk intelligence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Analytica.